TATACONSUM

is in advanced talks to buy Danone India's nutraceuticals and specialist nutrition business for a valuation close to being settled. The deal would expand Tata Consumer into the high-growth nutrition segment, competing with Nestlé and Abbott. Danone's nutrition portfolio includes Farex, Dexolac, and Protinex, growing faster than India's broader packaged food market.